Navigation Links
S*BIO Announces Collaboration with Onyx for JAK2 Inhibitors in the North American and European Markets
Date:1/6/2009

. S*BIO has links with a network of medical oncologists in Asia Pacific and its investors include Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. More information about S*BIO can be found at www.sbio.com.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treatedTM. The company in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small molecule drug. Nexavar is currently approved for the treatment of advanced kidney cancer and liver cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer and other cancers. For more information about Onyx, visit the company's website at http://www.onyx-pharm.com.

    S*BIO Pte Ltd:                    Russo Partners:
    Stephen Keith Rhind, Ph.D.        Tony Russo +1 212-845-4251
    Senior Vice President,            Tony.Russo@russopartnersllc.com
    Corporate Development
    Tel: +65 6827 5000 (Singapore)    Andreas Marathovouniotis +1 212-845-4253
    Stephen_rhind@sbio.com            Andreas.Marathis@russopartnersllc.com


'/>"/>
SOURCE S*BIO
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Preliminary Clinical Data Presented at the 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrate Superior Profile of S*BIOs Novel Anti-Cancer Drug SB939
2. S*BIOs Oral JAK2 Inhibitor SB1518 Demonstrates Therapeutic Potential for the Treatment of Myeloproliferative and Other Hematological Disorders
3. S*BIO Expands Pipeline With the Development of a Unique Flt3 -CDK Inhibitor as a Targeted Therapy for Acute Leukemias
4. MHA Announces Pegeen Butterfield, RN as Senior Vice President of Trade Relations
5. IMRIS announces first IMRISneuro project in Australia
6. Akrimax Pharmaceuticals Announces Manufacturing Partnership
7. Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist.
8. American Asthma Foundation Announces Breakthrough Discovery
9. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
10. WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder
11. DiFUSION Technologies Announces Company Launch Focused on Surgical Site Infections (SSIs)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... of the game later, doctors say , , SUND...he talk of the NFL this season, sidelining such st...llie Parker. , Officials at the American Podiat...diatric Sports Medicine are warning athletes to ta...ike football and lacrosse. , "Many fall sports ...
(Date:11/8/2009)...re-USNewswire/ -- Tonight the House of Representat... Act, landmark health reform legislation that will...rdable, stable and secure health care coverage. Th...surance industry,s worst practices, would extend c...t by $104 billion over ten years. Groups represent...
(Date:11/8/2009)...rying of biopharmaceuticals to be available at the..., Toronto, ON (PRWEB) Nove...of Therapure Biopharma Inc. today announced that t...e pharmaceutical grade freeze dryer and expects to...on) available for contract manufacturing of biopha...
(Date:11/8/2009)...re-USNewswire/ -- Today, the House of Representati...Smith, Ellsworth and Lipinski amendment to the "Af... The amendment maintains the current policy of pre...its packages that include abortion. It clarifies t...ity credits and those who do not, can with their o...
(Date:11/8/2009)...re-USNewswire/ -- USAction this evening hailed pas..., which will make health care more affordable for ...d increase access to health care for millions of A...sevelt, FDR and Harry Truman would be proud," said...vote ranks among our country,s proudest achievemen...
Breaking Medicine News(10 mins):Health News:Rx for Fall Foot Injuries 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2
...duced in the health care system to make doctors mo...nd Minister for Health, Mary Harney said that the ...reasing the number of commoners //on the Medical C...to the behavior of doctors. All this would he...
...ition to the prime minister to increase the suppor... have summoned support from both MPs and actress E...demonstration outside the Department of Health. Th...reastfeed in public in England. They also want the...
..., Andhra Pradesh, Tamil Nadu and Maharashtra are t...stop the rapid spread of Chikungunya.// The diseas...hs of people in the biggest occurrence after it ca... at the meeting. Chikungunya was confined to Kadap...
...ast cancer and vertebral fractures, but raise the ...tudy in the July 13 issue of the New England Journ...ear-long trial of more than 10,000 postmenopausal ...bral fractures and breast cancer, but an increased...
...alth minister E D Marak, who was hospitalised here... today, doctors said. // 'Marak's temparatur... His condition is improving,' Superintendent of st...g from a visit to the Malaria-prone Garo Hills on ...
...baxy Laboratories Ltd today said it had entered in...rtho Inc (JOI) for a generic version of Risperidon... The agreement was signed between Ranbaxy's who...t will provide Ranbaxy with an opportunity to comm...
Other Medicine News:Health News:Risks/Benefits of Osteoporosis Drug Use in Postmenopausal Women 2
(Date:11/6/2009)... 6 NexBio Inc., in collaboration w...and Prevention (CDC), St. Louis University, and th...lication of two articles in the peer-reviewed jour... that DAS181 (Fludase ® ) may play a potentia...n of the Pandemic Influenza A(H1N1) and drug-resis...
(Date:11/6/2009)...mber 6 , - Trial Will Com...the,Treatment of Multi-Resistant Staphylococcus Au...ality pharmaceutical company focused on the discov...to overcome the significant global,problem of micr...vanced oral,antibacterial NXL103 (flopristin/linop...
(Date:11/5/2009)... Calif., Nov. 5 Transcep...lty pharmaceutical company focused on the developm...that address important therapeutic needs in the fi...a webcast and teleconference with management to di...sday, November 12, 2009, at 5:00 p.m. Eastern Stan...
Breaking Medicine Technology:NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2New Website www loseadresssize com Launches 53709 1New Website www loseadresssize com Launches 53709 2Pharmacyclics Inc Rights Offering Oversubscribed 13381 1Pharmacyclics Inc Rights Offering Oversubscribed 13381 2Pharmacyclics Inc Rights Offering Oversubscribed 13381 3Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 1Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 2
...ement Studied in Largest-Ever IVF Trial,in US, RAN... Results of,four studies evaluating Ferring Pharma...inal insert in development for luteal phase,suppor...tion and,the early stages of pregnancy) in assiste...t the 55th Annual Meeting of the,Pacific Coast Rep...
...NESS WIRE)--Apr 18, 2007 - Avanir,Pharmaceuticals ...sults from the company,s Phase III clinical trial ...xtromethorphan,hydrobromide/quinidine sulfate ("DM...iabetic neuropathic pain., The primary endpoint of...r the Pain Rating Scale as defined in the Special,...
Other Medicine Technology:Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 2Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 3Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 4Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 6
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: